Published in Journal of Clinical Investigation · View the paper (DOI)
Natural Killer cells have been found to play a key role in responding to checkpoint inhibitors, which are transforming the treatment of cancer. Researchers discovered that these cells can produce the same checkpoint receptor molecules as T cells, enabling them to respond directly to the therapy.
Coverage from 2 institutions